210 



DECLARATION OF KEVIN M. BUDICH 



1. My name is Kevin M. Budich. I am employed by the Food and 

 Drug Administration (FDA) as a Compliance Officer in the OTC 

 Compliance Branch, Center for Drug Evaluation and Research. My 

 responsibilities in this position include work on FDA's 



investigation of the role of nicotine in cigarettes. 



2. On May 3, 1994, I accompanied other FDA representatives to a 

 Brown & Williamson (B&W) facility in Macon, Georgia. We met with 

 several B4W officials and their attorneys, including: Dewey Carter, 

 Rufus Honecutt, Kendrick Wells, Dan Snyder, Randy Harrison, Drew 

 McMurtrie, Sandra Cox, Gary Nicholson, Gene Pfeifer, and Gordon 

 Smith. 



3. During that meeting one of the FDA representatives asked a 

 number of questions about whether B&W monitored, manipulated, or 

 controlled nicotine in tobacco at various stages of cigarette 

 production. One of the questions asked by the FDA representatives 

 was whether B&W was involved in the development of either a higher 

 or lower nicotine variety of tobacco. Although I do not remember 

 specifically who responded to this question, one of the B&W 

 representatives stated that B&W was not involved in such 

 development. This response is reflected in my handwritten notes 

 taken during this meeting. I have attached the relevant page of my 

 notes. 



I declare under penalty of perjury that the foregoing is true and 

 correct. 21 U.S.C. 1746. 



l ^"n,.(^ .^j) 



Kevin M. Budich 

 Executed on this 22nd day of June, 1994, 



